This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
infection control | 252 |
hand hygiene | 199 |
healthcare workers | 178 |
systematic review | 164 |
respiratory syndrome | 147 |
intensive care | 130 |
central venous | 119 |
infectious diseases | 93 |
nosocomial infections | 91 |
health care | 89 |
protective equipment | 84 |
middle east | 82 |
syndrome coronavirus | 81 |
east respiratory | 78 |
care unit | 77 |
acute respiratory | 77 |
staphylococcus aureus | 73 |
personal protective | 71 |
hydrogen peroxide | 69 |
severe acute | 69 |
urinary tract | 67 |
risk factors | 66 |
infection prevention | 63 |
doc id | 62 |
hosp infect | 62 |
cord uid | 62 |
infect doi | 62 |
venous catheters | 61 |
coronavirus disease | 58 |
novel coronavirus | 54 |
nosocomial infection | 54 |
pylori infection | 53 |
bloodstream infection | 50 |
filtering facepiece | 50 |
surgical masks | 49 |
table i | 48 |
resistant staphylococcus | 46 |
face masks | 46 |
neonatal intensive | 45 |
south korea | 44 |
nosocomial transmission | 43 |
tract infections | 43 |
infection rates | 42 |
saudi arabia | 41 |
viral rna | 41 |
care workers | 40 |
surgical mask | 39 |
bloodstream infections | 38 |
respiratory tract | 38 |
healthcare settings | 38 |
related bloodstream | 37 |
insertion site | 37 |
control measures | 37 |
urinary catheters | 37 |
care units | 37 |
venous catheter | 37 |
facepiece respirators | 37 |
patient care | 36 |
total number | 36 |
respiratory viruses | 35 |
based hand | 35 |
influenza virus | 35 |
tract infection | 35 |
hygiene compliance | 35 |
hong kong | 34 |
world health | 34 |
bioaerosol sampling | 34 |
helicobacter pylori | 33 |
syncytial virus | 32 |
respiratory syncytial | 32 |
risk factor | 32 |
related infections | 31 |
hospital infection | 31 |
public health | 31 |
systematic reviews | 31 |
controlled trial | 31 |
airflow resistance | 30 |
hand rub | 30 |
sodium hypochlorite | 30 |
viral load | 30 |
parenteral nutrition | 30 |
control group | 29 |
urethral catheters | 28 |
indwelling urethral | 28 |
patient contact | 28 |
aerosol penetration | 28 |
ffr particle | 28 |
airborne transmission | 27 |
particle size | 27 |
environmental contamination | 27 |
randomised controlled | 27 |
respiratory symptoms | 27 |
associated infections | 27 |
acquired infections | 27 |
term indwelling | 27 |
primary research | 26 |
venous access | 26 |
particle penetration | 26 |
health organization | 26 |
cohort study | 25 |
catheter insertion | 25 |
infectious virus | 25 |
healthcare worker | 25 |
occupational exposure | 24 |
radiologically confirmed | 24 |
one study | 24 |
decontamination methods | 24 |
clinical diagnosis | 24 |
among healthcare | 23 |
isolation room | 23 |
medical staff | 23 |
may also | 23 |
confirmed hap | 23 |
aseptic technique | 23 |
safety threats | 22 |
critically ill | 22 |
fit test | 22 |
infectious disease | 22 |
hand decontamination | 22 |
full text | 22 |
filtration efficiency | 22 |
hospitalized patients | 22 |
disease control | 22 |
study reported | 21 |
decontamination cycles | 21 |
negative pressure | 21 |
contact times | 21 |
confirmed cases | 21 |
prospective study | 21 |
catheter colonisation | 21 |
mers outbreak | 21 |
liquid soap | 21 |
among hcws | 21 |
control team | 21 |
stainless steel | 21 |
study period | 21 |
significantly reduce | 21 |
time series | 20 |
face mask | 20 |
symptom onset | 20 |
acute care | 20 |
ivad use | 20 |
air flow | 20 |
review questions | 20 |
respiratory virus | 20 |
risk assessment | 20 |
hh compliance | 20 |
interrupted time | 20 |
infections associated | 20 |
confirmed covid | 20 |
following decontamination | 20 |
chain reaction | 20 |
eight days | 19 |
table ii | 19 |
sickness absence | 19 |
respiratory protection | 19 |
statistically significant | 19 |
associated urinary | 19 |
room temperature | 19 |
respirator masks | 19 |
access device | 18 |
quality improvement | 18 |
log reduction | 18 |
tested positive | 18 |
hepa filter | 18 |
surgical instruments | 18 |
table iii | 18 |
dromedary camels | 18 |
care settings | 18 |
ffr fit | 18 |
seven days | 18 |
clinical staff | 18 |
infected patients | 18 |
infection rate | 18 |
infection among | 18 |
cov infection | 17 |
fit factor | 17 |
united states | 17 |
control practices | 17 |
associated pneumonia | 17 |
polymerase chain | 17 |
healthcare personnel | 17 |
hand washing | 17 |
related complications | 17 |
isopropyl alcohol | 17 |
antimicrobial resistance | 17 |
environmental surfaces | 17 |
hospital environment | 17 |
ffr decontamination | 17 |
hh stations | 17 |
associated amyloid | 16 |
included studies | 16 |
another study | 16 |
increased risk | 16 |
close contacts | 16 |
generating procedures | 16 |
significantly lower | 16 |
uas treatment | 16 |
totobobo mask | 16 |
direct patient | 16 |
intervention group | 15 |
tertiary care | 15 |
hospitalised patients | 15 |
eye protection | 15 |
patient safety | 15 |
including phlebitis | 15 |
catheter tip | 15 |
idea model | 15 |
microbial contamination | 15 |
copies per | 15 |
mask performance | 15 |
three studies | 15 |
tip colonisation | 15 |
particle filtration | 15 |
beard cover | 15 |
controlled trials | 15 |
none declared | 15 |
surgical stainless | 15 |
serial interval | 15 |
premature line | 15 |
urethral catheter | 15 |
critically appraised | 15 |
care hospital | 15 |
internal jugular | 15 |
cfu cm | 15 |
urinary catheter | 15 |
line removal | 15 |
study showed | 15 |
intravascular catheter | 15 |
air samples | 15 |
significantly higher | 15 |
high risk | 14 |
diseases society | 14 |
ultraviolet germicidal | 14 |
prospective cohort | 14 |
close contact | 14 |
ed one | 14 |
urinary drainage | 14 |
best practice | 14 |
related infection | 14 |
three decontamination | 14 |
one patient | 14 |
administration sets | 14 |
emergency department | 14 |
hospital water | 14 |
germicidal irradiation | 14 |
pressure isolation | 14 |
intravascular access | 14 |
incubation period | 14 |
clinically indicated | 14 |
positive patients | 14 |
msb precautions | 14 |
safer sharps | 14 |
authors concluded | 14 |
chemical disinfectants | 14 |
performed using | 14 |
present study | 14 |
march th | 13 |
personal samplers | 13 |
social media | 13 |
occupational health | 13 |
ultrasonically activated | 13 |
access devices | 13 |
neonatal unit | 13 |
national institute | 13 |
care facilities | 13 |
decontamination interventions | 13 |
mask pieces | 13 |
inanimate surfaces | 13 |
coronavirus infection | 13 |
transmission dynamics | 13 |
relative humidity | 13 |
serial intervals | 13 |
lower respiratory | 13 |
clinical practice | 13 |
healthcare providers | 13 |
asymptomatic carriers | 13 |
general population | 13 |
significant difference | 13 |
facepiece respirator | 13 |
clinical trial | 12 |
international guidelines | 12 |
healthcare staff | 12 |
studies reported | 12 |
intravascular catheters | 12 |
sample size | 12 |
collection efficiency | 12 |
improve hand | 12 |
emerging infectious | 12 |
appropriate use | 12 |
index case | 12 |
children aged | 12 |
per patient | 12 |
acquired pneumonia | 12 |
mechanical ventilation | 12 |
sharps devices | 12 |
safety devices | 12 |
antimicrobial susceptibility | 12 |
hospital acquired | 12 |
surgical site | 12 |
routine use | 12 |
lumen catheters | 12 |
total parenteral | 12 |
clinical care | 12 |
nosocomial outbreaks | 12 |
surgical face | 12 |
latent safety | 12 |
hospital transmission | 12 |
infected brain | 12 |
commonly used | 12 |
least one | 12 |
official publication | 12 |
randomized controlled | 12 |
occupational safety | 12 |
ill patients | 11 |
virus infection | 11 |
symptomatic patients | 11 |
acinetobacter spp | 11 |
surgical patients | 11 |
brain homogenate | 11 |
many studies | 11 |
bed occupancy | 11 |
critical appraisal | 11 |
two studies | 11 |
silver sulfadiazine | 11 |
vaporized hydrogen | 11 |
safe use | 11 |
upper respiratory | 11 |
nursing staff | 11 |
additional evidence | 11 |
flow rate | 11 |
drainage system | 11 |
hygiene practice | 11 |
staff members | 11 |
guideline development | 11 |
observational study | 11 |
asymptomatic cases | 11 |
two years | 11 |
contact precautions | 11 |
drainage bag | 11 |
complications including | 11 |
developing world | 11 |
two weeks | 11 |
clinical characteristics | 11 |
viral contamination | 11 |
uas system | 11 |
particulate air | 11 |
efficiency particulate | 11 |
general medical | 11 |
hands must | 11 |
ffr models | 11 |
exposed persons | 11 |
bioaerosol particles | 11 |
lower risk | 11 |
randomized trial | 11 |
peripheral venous | 11 |
hospital trusts | 11 |
cases among | 11 |
mrsa acquisition | 11 |
september th | 11 |
mortality rate | 11 |
active sampling | 11 |
significant decrease | 11 |
insertion sites | 10 |
studies evaluated | 10 |
associated infection | 10 |
ethylene oxide | 10 |
control programme | 10 |
previous studies | 10 |
public places | 10 |
university hospital | 10 |
sharps injuries | 10 |
mucous membranes | 10 |
invasive procedures | 10 |
also found | 10 |
prevent catheter | 10 |
dry heat | 10 |
pseudomonas aeruginosa | 10 |
sampling device | 10 |
human transmission | 10 |
developing countries | 10 |
statistical analysis | 10 |
cant difference | 10 |
retrospective cohort | 10 |
catheter hub | 10 |
care centers | 10 |
negative bacteria | 10 |
influenza pandemic | 10 |
nc infection | 10 |
singh thattha | 10 |
currently available | 10 |
healthcare professionals | 10 |
sampling devices | 10 |
fit testing | 10 |
acquired infection | 10 |
social distancing | 10 |
per catheter | 10 |
needlestick injuries | 10 |
communicable diseases | 10 |
high prevalence | 10 |
educational interventions | 10 |
clinical course | 10 |
rv group | 10 |
evidence base | 10 |
settle plates | 10 |
rapidly evolving | 10 |
antibiotic use | 10 |
cov infections | 10 |
medical gloves | 10 |
among patients | 10 |
sars coronavirus | 10 |
teaching hospital | 10 |
antimicrobial agents | 10 |
tcid ml | 10 |
direct contact | 10 |
peripherally inserted | 10 |
hospital admission | 10 |
small number | 10 |
cov outbreak | 10 |
sick leave | 10 |
healthcare environments | 10 |
median age | 10 |
outpatient clinic | 10 |
keevil cw | 10 |
cohort studies | 10 |
five decontamination | 10 |
protective clothing | 10 |
pathogenic microorganisms | 10 |
may include | 10 |
respiratory pathogens | 10 |
sampling points | 10 |
endoscopy personnel | 10 |
compliance rates | 10 |
patients treated | 10 |
prevalence survey | 10 |
hospital settings | 10 |
endotracheal intubation | 10 |
interim guidance | 10 |
low birthweight | 10 |
based guidelines | 10 |
barrier precautions | 10 |
mers coronavirus | 10 |
cleaning chemistries | 9 |
critical care | 9 |
nucleic acid | 9 |
healthcare environment | 9 |
medical devices | 9 |
test set | 9 |
agar plate | 9 |
operating theatres | 9 |
respiratory protective | 9 |
hand contamination | 9 |
gloves must | 9 |
rna load | 9 |
bearded individuals | 9 |
front line | 9 |
confirmed case | 9 |
smaller particles | 9 |
healthcare practitioners | 9 |
single use | 9 |
drainage bags | 9 |
south korean | 9 |
may lead | 9 |
hospital setting | 9 |
significant differences | 9 |
case definition | 9 |
normal saline | 9 |
downstream penetration | 9 |
sputum samples | 9 |
clinical infectious | 9 |
coping behaviours | 9 |
preventing catheter | 9 |
medical costs | 9 |
hepa filters | 9 |
experimental studies | 9 |
orthopaedic surgery | 9 |
study design | 9 |
indwelling urinary | 9 |
personal protection | 9 |
silver alloy | 9 |
mask beard | 9 |
active surveillance | 9 |
fungal infections | 9 |
control interventions | 9 |
control precautions | 9 |
filtration factor | 9 |
recent study | 9 |
control bundle | 9 |
one rct | 9 |
haematology patients | 9 |
cochrane review | 9 |
vascular catheter | 9 |
five studies | 9 |
advisory group | 9 |
cov cases | 9 |
passive sampling | 9 |
intubated patients | 9 |
two groups | 9 |
glove use | 9 |
gastrointestinal tract | 9 |
th march | 9 |
asymptomatic sars | 9 |
first quarter | 9 |
activated stream | 9 |
thattha technique | 9 |
limited settings | 9 |
bone marrow | 9 |
six days | 9 |
human coronavirus | 9 |
expert opinion | 9 |
germicidal effects | 9 |
airborne pathogens | 9 |
catheter site | 9 |
decontamination using | 9 |
viral shedding | 9 |
resistant organisms | 9 |
reduce rates | 9 |
mrsa infections | 8 |
filter performance | 8 |
mers cases | 8 |
filter efficiency | 8 |
situ simulation | 8 |
associated bacteriuria | 8 |
widely used | 8 |
ed three | 8 |
operating theatre | 8 |
potentially contaminated | 8 |
peroxide vapour | 8 |
sterile gloves | 8 |
viral infections | 8 |
surface cleaning | 8 |
system interventions | 8 |
infectious sars | 8 |
primary outcome | 8 |
previous study | 8 |
th april | 8 |
articles retrieved | 8 |
health workers | 8 |
took place | 8 |
surface samples | 8 |
pathogenic bacteria | 8 |
healthcare facilities | 8 |
general wards | 8 |
prion proteins | 8 |
airborne bacteria | 8 |
control strategies | 8 |
published studies | 8 |
human metapneumovirus | 8 |
microbiology laboratory | 8 |
text review | 8 |
exhaled breath | 8 |
also tested | 8 |
povidone iodine | 8 |
described primary | 8 |
mechanical complications | 8 |
infectious dose | 8 |
emergency management | 8 |
mask use | 8 |
preventive measures | 8 |
sponge dressings | 8 |
one hcw | 8 |
surface stability | 8 |
isolation rooms | 8 |
respiratory infections | 8 |
may reduce | 8 |
invasive devices | 8 |
viral pathogens | 8 |
patients admitted | 8 |
reproduction number | 8 |
enhanced cleaning | 8 |
brain homogenates | 8 |
per ml | 8 |
staff member | 8 |
hand rubs | 8 |
see table | 8 |
respiratory viral | 8 |
hospital stay | 8 |
patients receiving | 8 |
low prevalence | 8 |
title abstract | 8 |
respiratory illness | 8 |
chlorhexidine silver | 8 |
effective hand | 8 |
chlorhexidine gluconate | 8 |
respirator mask | 8 |
reduce catheter | 8 |
study found | 8 |
previous systematic | 8 |
whilst updating | 8 |
analysed using | 8 |
control practice | 8 |
quaternary ammonium | 8 |
person transmission | 8 |
pathogen load | 8 |
intravenous antimicrobials | 8 |
dressing changes | 8 |
avian influenza | 8 |
coated urinary | 8 |
benzalkonium chloride | 8 |
peripheral intravenous | 8 |
amyloid removal | 8 |
site infection | 8 |
statistical computing | 8 |
respiratory droplets | 8 |
adult patients | 8 |
impregnated central | 8 |
case report | 8 |
healthcare associated | 8 |
different types | 7 |
index cases | 7 |
three cycles | 7 |
facial hair | 7 |
water stream | 7 |
patients presenting | 7 |
contamination may | 7 |
fever clinic | 7 |
isolation facilities | 7 |
family cluster | 7 |
stop orders | 7 |
hand disinfection | 7 |
bacterial contamination | 7 |
abstract indicates | 7 |
general public | 7 |
epoc criteria | 7 |
informs one | 7 |
viral loads | 7 |
prion protein | 7 |
lower levels | 7 |
health service | 7 |
positive pressure | 7 |
prevent spread | 7 |
supply chain | 7 |
hospital environmental | 7 |
confidence interval | 7 |
analysis including | 7 |
contaminated surfaces | 7 |
first outbreak | 7 |
tissue proteins | 7 |
airborne microbes | 7 |
several studies | 7 |
older people | 7 |
line hcw | 7 |
shear forces | 7 |
subtilis spores | 7 |
incidence rate | 7 |
droplet nuclei | 7 |
two appraisers | 7 |
cope study | 7 |
odds ratio | 7 |
inform one | 7 |
tested negative | 7 |
nasopharyngeal swabs | 7 |
handwashing technique | 7 |
bloodborne viruses | 7 |
stem cell | 7 |
three departments | 7 |
inclusion criteria | 7 |
acquired urinary | 7 |
nosocomial outbreak | 7 |
inserted central | 7 |
studies selected | 7 |
supporting evidence | 7 |
health organisation | 7 |
study also | 7 |
surface contamination | 7 |
emergency departments | 7 |
plastic aprons | 7 |
among health | 7 |
physical traits | 7 |
timely removal | 7 |
control guidelines | 7 |
protection agency | 7 |
susceptibility patterns | 7 |
impregnated catheters | 7 |
medical surveillance | 7 |
skin irritation | 7 |
late indeterminate | 7 |
clinical areas | 7 |
touch surfaces | 7 |
bacterial count | 7 |
contact tracing | 7 |
symptomatic hcws | 7 |
sift criteria | 7 |
compliance rate | 7 |
observational studies | 7 |
low risk | 7 |
may result | 7 |
unprotected exposure | 7 |
logistic regression | 7 |
environmental cleaning | 7 |
decontamination procedures | 7 |
pilot study | 7 |
air quality | 7 |
negative bacilli | 7 |
term care | 7 |
resistant enterococci | 7 |
using sign | 7 |
ffr function | 7 |
central catheter | 7 |
intervention arms | 7 |
directly observed | 7 |
development advisory | 7 |
cold water | 7 |
potential source | 7 |
th may | 7 |
maximal sterile | 7 |
appraisers using | 7 |
negative staphylococci | 7 |
many hospitals | 7 |
detection limit | 7 |
bioaerosol sampler | 7 |
national nosocomial | 7 |
ffp mask | 7 |
potential risk | 7 |
catheterrelated infections | 7 |
general ward | 7 |
mask decontamination | 7 |
august th | 7 |
aerosol generating | 7 |
chemical disinfectant | 7 |
virus outbreak | 7 |
intact skin | 7 |
filter penetration | 7 |
guideline recommendations | 7 |
data collection | 7 |
test conditions | 7 |
local guidelines | 7 |
ed two | 7 |
eight studies | 7 |
infection associated | 7 |
prevalence surveys | 7 |
pylori prevalence | 7 |
cumulative incidence | 7 |
virus stock | 7 |
catheter care | 7 |
static samplers | 7 |
preterm neonates | 7 |
clostridium difficile | 7 |
independently critically | 7 |
nosocomial pneumonia | 7 |
paediatric intensive | 7 |
particles will | 7 |
april th | 7 |
nursery environment | 7 |
sampling time | 7 |
virus transmission | 7 |
soy agar | 7 |
mask layer | 7 |
asymptomatic patients | 7 |
ppe use | 7 |
must also | 7 |
data analysis | 6 |
pyeongtaek hospital | 6 |
available data | 6 |
samples taken | 6 |
tracheal aspirate | 6 |
remain suspended | 6 |
tryptic soy | 6 |
much lower | 6 |
environmental hygiene | 6 |
citation screening | 6 |
oseltamivir treatment | 6 |
efficient removal | 6 |
methicillinresistant staphylococcus | 6 |
equipment used | 6 |
respiratory samples | 6 |
isolation ward | 6 |
th february | 6 |
sharps injury | 6 |
procedural protocols | 6 |
filtering face | 6 |
patients may | 6 |
reduce risk | 6 |
made available | 6 |
severe respiratory | 6 |
studies suggest | 6 |
evolving epidemiology | 6 |
microbial burden | 6 |
care personnel | 6 |
mrsa control | 6 |
airborne route | 6 |
table iv | 6 |
airborne precautions | 6 |
nested pcr | 6 |
evidence currently | 6 |
hospital staff | 6 |
resistant tuberculosis | 6 |
aged years | 6 |
clinical environment | 6 |
resistant bacteria | 6 |
iss programme | 6 |
pressure drop | 6 |
intravenous fluids | 6 |
transmission risk | 6 |
developed countries | 6 |
hospital rooms | 6 |
practice guidelines | 6 |
observational cohort | 6 |
rna loads | 6 |
gestational age | 6 |
bacillus subtilis | 6 |
articles located | 6 |
infection prevalence | 6 |
decontamination cycle | 6 |
neonatal units | 6 |
prevent transmission | 6 |
catheterrelated bloodstream | 6 |
risks associated | 6 |
hepa filtration | 6 |
intravenous catheters | 6 |
multicenter study | 6 |
tissue protein | 6 |
agar plates | 6 |
respiratory infection | 6 |
somewhat confident | 6 |
safety concerns | 6 |
will also | 6 |
cell culture | 6 |
provided evidence | 6 |
effective infection | 6 |
two consecutive | 6 |
long periods | 6 |
improve clarity | 6 |
control nurse | 6 |
mm diameter | 6 |
quality whilst | 6 |
previous guidelines | 6 |
vascular access | 6 |
rates compared | 6 |
pseudomonas spp | 6 |
ffr performance | 6 |
exposure prophylaxis | 6 |
potential pathogens | 6 |
human infection | 6 |
infectious particles | 6 |
current national | 6 |
outbreak situations | 6 |
become contaminated | 6 |
first cases | 6 |
neonatal infections | 6 |
oncology patients | 6 |
cov antibodies | 6 |
cutaneous antisepsis | 6 |
single cycle | 6 |
infection risk | 6 |
possible cases | 6 |
evidence explicitly | 6 |
cluster rct | 6 |
three times | 6 |
mild symptoms | 6 |
highly effective | 6 |
use application | 6 |
randomised trial | 6 |
negative pcr | 6 |
preterm infants | 6 |
ivad administration | 6 |
significant risk | 6 |
higher risk | 6 |
healthcare setting | 6 |
small sample | 6 |
polyurethane dressings | 6 |
clinical symptoms | 6 |
staff self | 6 |
tunnelled cvcs | 6 |
one systematic | 6 |
airborne particles | 6 |
viral copies | 6 |
adverse effects | 6 |
jakob disease | 6 |
united kingdom | 6 |
coronavirus rna | 6 |
randomized clinical | 6 |
human immunodeficiency | 6 |
three months | 6 |
nosocomial bloodstream | 6 |
site infections | 6 |
day care | 6 |
acquired covid | 6 |
three years | 6 |
nasopharyngeal swab | 6 |
two different | 6 |
rsv season | 6 |
economic evaluation | 6 |
health outpatient | 6 |
tract samples | 6 |
appraised evidence | 6 |
aged less | 6 |
haematology ward | 6 |
coated catheters | 6 |
explicitly linked | 6 |
crossover study | 6 |
clinical settings | 6 |
influenza viral | 6 |
surveillance cultures | 6 |
special reference | 6 |
preventing nosocomial | 6 |
nucleic acids | 6 |
pandemic influenza | 6 |
point prevalence | 6 |
surgical procedures | 6 |
thrombus formation | 6 |
detailed procedural | 6 |
nosocomial pathogens | 6 |
ionized hydrogen | 6 |
six patients | 6 |
exact test | 6 |
six studies | 6 |
npa samples | 6 |
infectious agents | 6 |
positive results | 6 |
urethral trauma | 6 |
aetiological agents | 6 |
traffic volume | 6 |
steel surfaces | 6 |
wide range | 6 |
medical masks | 6 |
infections surveillance | 6 |
virtual impactors | 6 |
air conditioning | 6 |
cases per | 6 |
fit following | 6 |
indoor air | 6 |
onset date | 6 |
prevention measures | 6 |
bioaerosol samplers | 6 |
even though | 6 |
us hospitals | 6 |
latex gloves | 6 |
lung disease | 6 |
lower rates | 6 |
term catheterisation | 6 |
hd patients | 6 |
bioaerosol material | 6 |
water systems | 6 |
three weeks | 6 |
us study | 6 |
large number | 6 |
multiple interventions | 6 |
icu admission | 6 |
disease severity | 6 |
resistant enterococcus | 6 |
following three | 6 |
neonatal septicemia | 6 |
best critically | 6 |
protective effect | 6 |
acceptable quality | 6 |
air filtration | 6 |
size range | 6 |
like illness | 6 |
severe pneumonia | 6 |
national guidelines | 6 |
neonatal care | 6 |
medical center | 6 |
methicillin resistant | 6 |
environmental conditions | 6 |
hygiene guidelines | 6 |
various studies | 6 |
visibly soiled | 6 |
ttv dna | 6 |
wastewater treatment | 6 |
patient rooms | 6 |
non covid | 6 |
bacterial pathogens | 6 |
immunodeficiency virus | 6 |
bacterial load | 6 |
health england | 6 |
indeterminate cases | 6 |
totobobo masks | 6 |
group compared | 6 |
organic material | 6 |
infections caused | 6 |
per day | 6 |
single rooms | 6 |
patient group | 6 |
prevalence rate | 6 |
positive patient | 5 |
respiratory diseases | 5 |
catheter placement | 5 |
natural rubber | 5 |
inactivating hcov | 5 |
wearing gloves | 5 |
masks may | 5 |
replicate ffrs | 5 |
vary considerably | 5 |
active samplers | 5 |
care facility | 5 |
referral hospital | 5 |
available evidence | 5 |
surveillance studies | 5 |
rsv outbreaks | 5 |
sterilized masks | 5 |
population heterogeneity | 5 |
study lead | 5 |
clinically effective | 5 |
test results | 5 |
sputum sample | 5 |
reducing nosocomial | 5 |
hajj pilgrims | 5 |
nosocomial acquisition | 5 |
aureus control | 5 |
klebsiella spp | 5 |
sampling techniques | 5 |
rna detection | 5 |
will provide | 5 |
patients undergoing | 5 |
venous catheterization | 5 |
gauze mask | 5 |
human coronaviruses | 5 |
antimicrobial therapy | 5 |
following one | 5 |
may pose | 5 |
klebsiella pneumoniae | 5 |
screening swabs | 5 |
observed hand | 5 |
human lives | 5 |
waste management | 5 |
composting facilities | 5 |
affect ffr | 5 |
process evaluation | 5 |
medical personnel | 5 |
literature review | 5 |
clinical presentation | 5 |
bsi per | 5 |
young children | 5 |
particulate matter | 5 |
symptomatic staff | 5 |
ffr types | 5 |
hospital hygiene | 5 |
cases according | 5 |
following exposure | 5 |
sodium chloride | 5 |
gelatin filters | 5 |
np samples | 5 |
sampling period | 5 |
ox serum | 5 |
multiple cycles | 5 |
impaction plates | 5 |
potentially pathogenic | 5 |
peroxide vapor | 5 |
study risk | 5 |
shoe covers | 5 |
patient flow | 5 |
preventing infections | 5 |
studies published | 5 |
respiratory secretions | 5 |
transmission via | 5 |
percutaneous injury | 5 |
urinary catheterization | 5 |
changes per | 5 |
airborne microbial | 5 |
catheter colonization | 5 |
united nations | 5 |
breathing zone | 5 |
hospital outbreak | 5 |
second systematic | 5 |
cleaning practices | 5 |
compared using | 5 |
human activity | 5 |
tipped catheters | 5 |
steam sterilization | 5 |
pharmacological interventions | 5 |
respirators effects | 5 |
experimental study | 5 |
per year | 5 |
remain infectious | 5 |
separate rooms | 5 |
rubber latex | 5 |
radiological evidence | 5 |
physical distancing | 5 |
respirator fit | 5 |
case series | 5 |
log tcid | 5 |
risk assessments | 5 |
spiked influenza | 5 |
principal investigator | 5 |
respiratory sample | 5 |
remain airborne | 5 |
containing chlorhexidine | 5 |
bioaerosol concentration | 5 |
mask fitting | 5 |
three different | 5 |
control response | 5 |
resistant pathogens | 5 |
standard deviation | 5 |
resistant acinetobacter | 5 |
medical device | 5 |
aerosol transmission | 5 |
viral respiratory | 5 |
communicable disease | 5 |
satellite units | 5 |
medical attention | 5 |
collection probe | 5 |
activated water | 5 |
two reviewers | 5 |
particle count | 5 |
cystic fibrosis | 5 |
four major | 5 |
respiratory distress | 5 |
hospital wards | 5 |
local policies | 5 |
incidence decay | 5 |
may contribute | 5 |
first case | 5 |
transplant unit | 5 |
organ failure | 5 |
detection rate | 5 |
related thrombosis | 5 |
clinical management | 5 |
two patients | 5 |
upper extremity | 5 |
study used | 5 |
physical appearance | 5 |
alcohol hand | 5 |
cile infection | 5 |
maternal genital | 5 |
pressure rooms | 5 |
cant reduction | 5 |
viral infectivity | 5 |
related bacteremia | 5 |
indwelling catheters | 5 |
study group | 5 |
acinetobacter baumannii | 5 |
rsv group | 5 |
control groups | 5 |
tcid reduction | 5 |
bacterial flora | 5 |
sift full | 5 |
infections among | 5 |
february th | 5 |
overnight broth | 5 |
mrsa bacteraemia | 5 |
previously described | 5 |
virus infections | 5 |
penetration post | 5 |
physical degradation | 5 |
medical equipment | 5 |
extended use | 5 |
respiratory failure | 5 |
escalating infection | 5 |
enveloped viruses | 5 |
laden air | 5 |
studies conducted | 5 |
study using | 5 |
mers outbreaks | 5 |
hospital cleaning | 5 |
pcr results | 5 |
urinary retention | 5 |
totally implantable | 5 |
breast milk | 5 |
associated risk | 5 |
health protection | 5 |
vascular catheters | 5 |
forming units | 5 |
four patients | 5 |
different sampling | 5 |
one day | 5 |
hh ratio | 5 |
study results | 5 |
located abstract | 5 |
perceived vulnerability | 5 |
current study | 5 |
flow rates | 5 |
different groups | 5 |
term cvcs | 5 |
protein removal | 5 |
district hospital | 5 |
exponential adjustment | 5 |
viral transmission | 5 |
target pathogen | 5 |
undertaken using | 5 |
patients requiring | 5 |
chronic obstructive | 5 |
major risk | 5 |
marrow transplant | 5 |
serum broth | 5 |
hygiene products | 5 |
community acquired | 5 |
moist heat | 5 |
day medical | 5 |
cov case | 5 |
bladder scanners | 5 |
spectrum antimicrobials | 5 |
publicly available | 5 |
sharp instruments | 5 |
psychological impact | 5 |
prospective randomised | 5 |
catheter use | 5 |
exposure limits | 5 |
confirmed mers | 5 |
coronavirus infections | 5 |
routine replacement | 5 |
wearing face | 5 |
blood products | 5 |
various disinfectants | 5 |
bacterial infections | 5 |
important factor | 5 |
high levels | 5 |
ffp masks | 5 |
nurse staffing | 5 |
frequently used | 5 |
modified ss | 5 |
fever clinics | 5 |
cell transplant | 5 |
based solutions | 5 |
evidence suggests | 5 |
surface disinfectant | 5 |
acute hospital | 5 |
positive samples | 5 |
operating room | 5 |
gastrointestinal symptoms | 5 |
reduce urinary | 5 |
transparent polyurethane | 5 |
extracted using | 5 |
low quality | 5 |
sampling port | 5 |
relatively low | 5 |
despite negative | 5 |
trained staff | 5 |
catheter type | 5 |
sars epidemic | 5 |
symptoms consistent | 5 |
prevent cr | 5 |
aureus bacteraemia | 5 |
cruise ship | 5 |
disease transmission | 5 |
percutaneous injuries | 5 |
neonatal sepsis | 5 |
standard principles | 5 |
first days | 5 |
sars outbreak | 5 |
human adenovirus | 5 |
skin antisepsis | 5 |
floor level | 5 |
ventilated patients | 5 |
age group | 5 |
may occur | 5 |
laboratory services | 5 |
respiratory support | 5 |
standard infection | 5 |
birth weight | 5 |
remained viable | 5 |
air changes | 5 |
studies accepted | 5 |
factors associated | 5 |
genital tract | 5 |
internal medicine | 5 |
potential covid | 5 |
study designs | 5 |
viral nucleic | 5 |
handwashing song | 5 |
rate ratio | 5 |
royal college | 5 |
three groups | 5 |
sterile barrier | 5 |
contact time | 5 |
mrsa bundle | 5 |
one week | 5 |
median time | 5 |
clinical guidelines | 5 |
national evidence | 5 |
mildly symptomatic | 5 |
use items | 5 |
healthcare infection | 5 |
respiratory pathogen | 5 |
studies found | 5 |
related sepsis | 5 |
uc use | 5 |
familial cluster | 5 |
site care | 5 |
health emergency | 5 |
seasonal influenza | 5 |
respirator filtration | 5 |
control policies | 5 |
distinct interventions | 5 |
may become | 5 |
interim case | 5 |
catheter sepsis | 5 |
lumen central | 5 |
particle diameter | 5 |
surveillance system | 5 |
per hour | 5 |
different concentrations | 5 |
centrifugal force | 5 |
virus detection | 5 |
laboratory studies | 5 |
total protein | 5 |
larger particles | 5 |
escherichia coli | 5 |
clinical specimens | 5 |
second wave | 5 |
studies rejected | 5 |
ffr appearance | 5 |
korean outbreaks | 5 |
receiving intravenous | 5 |
infections acquired | 5 |
infection society | 4 |
education programme | 4 |
relatively short | 4 |
surgical infections | 4 |
also significantly | 4 |
radiology department | 4 |
recent review | 4 |
together vigorously | 4 |
medical centre | 4 |
particle sizes | 4 |
particle counts | 4 |
protection measures | 4 |
appraisal total | 4 |
small numbers | 4 |
positive pcr | 4 |
routine screening | 4 |
pneumonia occurring | 4 |
reduce transmission | 4 |
traits following | 4 |
transmission within | 4 |
infected patient | 4 |
airborne viruses | 4 |
pathogens including | 4 |
cant reductions | 4 |
paying particular | 4 |
studies indicated | 4 |
improve patient | 4 |
secondary outcomes | 4 |
spectrum beta | 4 |
reduce hospital | 4 |
meatal care | 4 |
blood donors | 4 |
severe disease | 4 |
clinical experience | 4 |
sterilization process | 4 |
waste stream | 4 |
secondary outcome | 4 |
epidemiological history | 4 |
changed every | 4 |
prospective surveillance | 4 |
control nurses | 4 |
structural integrity | 4 |
medical care | 4 |
indwelling central | 4 |
hygiene agents | 4 |
mask types | 4 |
contaminated hands | 4 |
distilled water | 4 |
cov transmission | 4 |
cps copies | 4 |
fluconazole prophylaxis | 4 |
absence due | 4 |
total bacterial | 4 |
current guidance | 4 |
primary case | 4 |
hand wipes | 4 |
recently published | 4 |
aseptic insertion | 4 |
standard cleaning | 4 |
free text | 4 |
cyclone sampler | 4 |
review included | 4 |
clinical setting | 4 |
sporadic incidents | 4 |
will increase | 4 |
achieved following | 4 |
contact transmission | 4 |
using abhr | 4 |
antimicrobial treatment | 4 |
laparoscopic versus | 4 |
data points | 4 |
cleaning toys | 4 |
hospital management | 4 |
peroxide levels | 4 |
healthcare products | 4 |
influenza vaccination | 4 |
highly sensitive | 4 |
reported covid | 4 |
health research | 4 |
severe shortages | 4 |
persistent disease | 4 |
air ventilation | 4 |
pulmonary disease | 4 |
catheterised patients | 4 |
settle plate | 4 |
control strategy | 4 |
rna viruses | 4 |
surgical ward | 4 |
illness among | 4 |
patient environment | 4 |
iss team | 4 |
contaminated hospital | 4 |
lipidcontaining parenteral | 4 |
world setting | 4 |
real time | 4 |
two hcws | 4 |
proper cleaning | 4 |
blood cultures | 4 |
transmission among | 4 |
respiratory droplet | 4 |
ocular surface | 4 |
using msb | 4 |
injuries among | 4 |
admitted covid | 4 |
infectious prion | 4 |
section discusses | 4 |
ward setting | 4 |
analysis showed | 4 |
rapid review | 4 |
aerosol particles | 4 |
vein thrombosis | 4 |
mrsa infection | 4 |
relative risk | 4 |
identifi ed | 4 |
six months | 4 |
gas plasma | 4 |
log decrease | 4 |
also indicated | 4 |
laboratory personnel | 4 |
published data | 4 |
repellent surgical | 4 |
virucidal efficacy | 4 |
viral particles | 4 |
ethics committee | 4 |
broth culture | 4 |
complications adverse | 4 |
less likely | 4 |
workers must | 4 |
diabetes mellitus | 4 |
september st | 4 |
aspirate sample | 4 |
prior room | 4 |
frequently associated | 4 |
referral hospitals | 4 |
collected particles | 4 |
two days | 4 |
intravenous therapy | 4 |
case definitions | 4 |
corona virus | 4 |
also important | 4 |
adult intensive | 4 |
cross infection | 4 |
physical characteristics | 4 |
catheter inserted | 4 |
either rsv | 4 |
step technique | 4 |
nursing facility | 4 |
water supply | 4 |
protective gloves | 4 |
bloodborne pathogens | 4 |
potentially lead | 4 |
jugular vein | 4 |
isolation wards | 4 |
washing solutions | 4 |
regulatory agency | 4 |
different methods | 4 |
hospital bed | 4 |
coronary artery | 4 |
endemic hospital | 4 |
needlestick injury | 4 |
ats idsa | 4 |
adverse events | 4 |
lessons learned | 4 |
prophylactic fluconazole | 4 |
bladder irrigation | 4 |
rubbed together | 4 |
time reverse | 4 |
days vs | 4 |
term central | 4 |
airborne microorganisms | 4 |
patients died | 4 |
daycare nurseries | 4 |
subclavian vein | 4 |
involving direct | 4 |
also used | 4 |
repellent gowns | 4 |
limited reuse | 4 |
faecal specimen | 4 |
also investigated | 4 |
reverse transcriptionepolymerase | 4 |
surgical infection | 4 |
true positives | 4 |
particular attention | 4 |
healthcare system | 4 |
true negatives | 4 |
efficiency dependent | 4 |
filtration performance | 4 |
suspected hap | 4 |
samsung hospital | 4 |
uv light | 4 |
adjustment model | 4 |
equipment must | 4 |
english language | 4 |
subcutaneous port | 4 |
future studies | 4 |
intravenous catheter | 4 |
injury prevention | 4 |
chg solution | 4 |
university medical | 4 |
diagnostic criteria | 4 |
aspirate samples | 4 |
informed consent | 4 |
significant proportion | 4 |
staff screening | 4 |
demonstrated efficient | 4 |
overall population | 4 |
immunocompromised patients | 4 |
laboratory testing | 4 |
infected neonates | 4 |
revised interim | 4 |
impregnated catheter | 4 |
random effects | 4 |
epic guidelines | 4 |
reverse transcription | 4 |
rational use | 4 |
nitrocellulose membranes | 4 |
discharged home | 4 |
immune system | 4 |
outcome measures | 4 |
research ethics | 4 |
nosocomial urinary | 4 |
recent systematic | 4 |
products regulatory | 4 |
solution must | 4 |
use safer | 4 |
early recognition | 4 |
using chemical | 4 |
often overlooked | 4 |
chronic lung | 4 |
less frequently | 4 |
one hundred | 4 |
per inpatient | 4 |
daily basis | 4 |
associated covid | 4 |
deep breathing | 4 |
outdoor ach | 4 |
two rcts | 4 |
peer review | 4 |
hh adherence | 4 |
retrospective study | 4 |
mannitol broth | 4 |
preventing healthcare | 4 |
hospital infections | 4 |
poorest communities | 4 |
new recommendation | 4 |
yellow dust | 4 |
confirmed patients | 4 |
fitting respirator | 4 |
bed tertiary | 4 |
electronic databases | 4 |
sleeved clothing | 4 |
published literature | 4 |
neonatal hai | 4 |
fan inlet | 4 |
standard operating | 4 |
nice guidelines | 4 |
line listing | 4 |
patient discomfort | 4 |
control recommendations | 4 |
considered statistically | 4 |
tsi incorporated | 4 |
haemodialysis patients | 4 |
universal precautions | 4 |
healthcare systems | 4 |
hospital surfaces | 4 |
results suggest | 4 |
daily meatal | 4 |
measured using | 4 |
potential solution | 4 |
organisations must | 4 |
catheters coated | 4 |
ffrs using | 4 |
clinical effectiveness | 4 |
heat decontamination | 4 |
patient isolation | 4 |
infectious patients | 4 |
well established | 4 |
trend towards | 4 |
one cycle | 4 |
commonly reported | 4 |
greater compliance | 4 |
adult inpatients | 4 |
bacterial counts | 4 |
us centers | 4 |
bacterial growth | 4 |
clinical records | 4 |
eligibility criteria | 4 |
cdc criteria | 4 |
underlying haematological | 4 |
microbial air | 4 |
reduced risk | 4 |
development goals | 4 |
major role | 4 |
hospital work | 4 |
line healthcare | 4 |
appropriate intravascular | 4 |
clinical features | 4 |
infected person | 4 |
nhs hospitals | 4 |
mass masking | 4 |
staff sickness | 4 |
hospital trust | 4 |
selective mannitol | 4 |
continuing use | 4 |
decontamination intervention | 4 |
nc patients | 4 |
foreign language | 4 |
ventilator associated | 4 |
rice cooker | 4 |
arterial catheters | 4 |
three categories | 4 |
normal breathing | 4 |
provide protection | 4 |
plates containing | 4 |
international development | 4 |
inpatient wards | 4 |
patients without | 4 |
spectrum antibiotics | 4 |
urti symptoms | 4 |
isolation precautions | 4 |
ksa outbreaks | 4 |
cancer centre | 4 |
abstract screening | 4 |
studies used | 4 |
potentially infectious | 4 |
subjects achieving | 4 |
bioaerosol samples | 4 |
face piece | 4 |
laboratory confirmation | 4 |
wash hands | 4 |
nosocomial spread | 4 |
may provide | 4 |
alcohol solution | 4 |
known pathogen | 4 |
events including | 4 |
emergency room | 4 |
symptomatic urinary | 4 |
containing mm | 4 |
appropriate waste | 4 |
many countries | 4 |
previously demonstrated | 4 |
antibiotic policies | 4 |
virus shedding | 4 |
measures implemented | 4 |
information regarding | 4 |
nosocomial covid | 4 |
potential safety | 4 |
early detection | 4 |
different prion | 4 |
high numbers | 4 |
viable virus | 4 |
peracetic acid | 4 |
transmission routes | 4 |
british standards | 4 |
environmental surface | 4 |
acquisition rates | 4 |
cycle iss | 4 |
selective reporting | 4 |
study demonstrated | 4 |
air contamination | 4 |
infectious air | 4 |
higher percentage | 4 |
particle counter | 4 |
specimen collection | 4 |
air filters | 4 |
mers viruses | 4 |
vinyl gloves | 4 |
sharps must | 4 |
surface sampling | 4 |
ace wards | 4 |
acute nhs | 4 |
patients diagnosed | 4 |
two large | 4 |
hospital workers | 4 |
antiseptic handwash | 4 |
clinical outcomes | 4 |
evaluated ffr | 4 |
house officer | 4 |
liquid hydrogen | 4 |
nosocomial mers | 4 |
airflow rate | 4 |
bacterial pathogen | 4 |
care bundle | 4 |
bacillus spp | 4 |
cac patients | 4 |
culture infectious | 4 |
antibiotic prescription | 4 |
hcw transmission | 4 |
cdc guidelines | 4 |
infected people | 4 |
single ctns | 4 |
intravascular devices | 4 |
cytopathic changes | 4 |
indwelling catheter | 4 |
gown use | 4 |
comprehensive strategy | 4 |
versus open | 4 |
environmental features | 4 |
reverse transcriptase | 4 |
mask may | 4 |
different levels | 4 |
influenza season | 4 |
st paul | 4 |
brother john | 4 |
year period | 4 |
safety legislation | 4 |
lower rate | 4 |
protection equipment | 4 |
outbreak control | 4 |
tissue culture | 4 |
healthcare organisations | 4 |
clinical microbiology | 4 |
controlled studies | 4 |
hospital administration | 4 |
series study | 4 |
original research | 4 |
clinical indication | 4 |
respondents felt | 4 |
hand sanitizer | 4 |
mass spectrometry | 4 |
factor following | 4 |
experimental conditions | 4 |
symptomatic cases | 4 |
sampling methods | 4 |
throat swab | 4 |
washing hands | 4 |
outbreak reports | 4 |
prolonged los | 4 |
practices advisory | 4 |
air sample | 4 |
skilled nursing | 4 |
various healthcare | 4 |
totally implanted | 4 |
ambient air | 4 |
became infected | 4 |
nasopharyngeal aspirate | 4 |
penetration following | 4 |
may still | 4 |
continuing professional | 4 |
particles per | 4 |
without radiological | 4 |
outdoor air | 4 |
national health | 4 |
negative results | 4 |
control committee | 4 |
viruses may | 4 |
reference lists | 4 |
data extraction | 4 |
smoking status | 4 |
hard surfaces | 4 |
interventions applied | 4 |
haematological malignancies | 4 |
reduce airborne | 4 |
control issue | 4 |
much higher | 4 |
enterobacter spp | 4 |
computed tomography | 4 |
sore throat | 4 |
transcriptionepolymerase chain | 4 |
filter material | 4 |
imported case | 4 |
torque teno | 4 |
antibiotic therapy | 4 |
products available | 4 |
promega italia | 4 |
many public | 4 |
global health | 4 |
controlled study | 4 |
readily transferred | 4 |
asymptomatic carrier | 4 |
mini kit | 4 |
assessment indicates | 4 |
outbreak investigation | 4 |
first week | 4 |
results indicate | 4 |
incidence density | 4 |
gsp samplers | 4 |
years ago | 4 |
air sampling | 4 |
observations related | 4 |
outbreak cluster | 4 |
device walls | 4 |
rsv infection | 4 |
facemask ppe | 4 |
viral pathogen | 4 |
extremely low | 4 |
korea mers | 4 |
nitrile gloves | 4 |
chest imaging | 4 |
rapid cycle | 4 |
advisory committee | 4 |
surveillance programmes | 4 |
grey bars | 4 |
gastrointestinal infections | 4 |
inertial impaction | 4 |
severe covid | 4 |
data obtained | 4 |
cvcs inserted | 4 |
cell count | 4 |
interquartile range | 4 |
time period | 4 |
disinfection procedures | 4 |
symptomatic patient | 4 |
general surgery | 4 |
infants born | 4 |
post uas | 4 |
seasonal variation | 4 |
reduction factor | 4 |
infected pneumonia | 4 |
teno virus | 4 |
generally considered | 4 |
short period | 4 |
clinical equipment | 4 |
radiological confirmation | 4 |
correct method | 4 |
products containing | 4 |
language papers | 4 |
masks respirators | 4 |
one nrct | 4 |
clinical use | 4 |
relatively small | 4 |
disinfectant type | 4 |
treatment plants | 4 |
suspected sars | 4 |
antiseptic solutions | 4 |
cov rna | 4 |
infection may | 4 |
three patients | 4 |
represent percentage | 4 |
multiple concentrations | 4 |
clinical isolates | 4 |
viable mrsa | 4 |
bacterial concentration | 4 |
ventilation systems | 4 |
sars case | 4 |
enterobacter cloacae | 4 |
may reflect | 4 |
better nutrition | 4 |
lock solutions | 4 |
current practice | 4 |
appropriate infection | 4 |
febrile patients | 4 |
stryker flyte | 4 |
also associated | 4 |
educational programme | 4 |
global pandemic | 4 |
dashes represent | 4 |
exposure time | 4 |
control policy | 4 |
experimental set | 4 |
recent report | 4 |
robust evidence | 4 |
professional education | 4 |
old man | 4 |
susceptible sites | 4 |
catheter hubs | 4 |
rna positive | 4 |
community hospital | 4 |
mycobacterium tuberculosis | 4 |
underlying illness | 4 |
nasal carriage | 4 |
epidemiological link | 4 |
gastrointestinal endoscopy | 4 |
must come | 4 |
hse books | 4 |
case investigation | 4 |
antiseptic soap | 4 |
care activities | 4 |
significant reduction | 4 |
three data | 4 |
basic reproduction | 4 |
following treatment | 4 |
higher rates | 4 |
hand sanitizers | 4 |
cell cultures | 4 |
haematology unit | 4 |
guidelines recommend | 4 |
found within | 3 |
thattha tied | 3 |
study data | 3 |
weakly positive | 3 |
community transmission | 3 |
aerosol sampler | 3 |
six replicate | 3 |
absence among | 3 |
first covid | 3 |
catheters reduce | 3 |
particles size | 3 |
hospitals need | 3 |
central catheters | 3 |
average number | 3 |
masks available | 3 |
catheter infections | 3 |
greater understanding | 3 |
droplets containing | 3 |
increased gradually | 3 |
one room | 3 |
fit tester | 3 |
staff caring | 3 |
huh cells | 3 |
natural hosts | 3 |
catheter replacement | 3 |
hcw felt | 3 |
th tested | 3 |
active ingredient | 3 |
household equipment | 3 |
greater risk | 3 |
severely ill | 3 |
pcr amplification | 3 |
virucidal activity | 3 |
covid wards | 3 |
new staff | 3 |
candida species | 3 |
outcome data | 3 |
cov using | 3 |
sharps containers | 3 |
richards model | 3 |
improved hand | 3 |
collected using | 3 |
subclavian venous | 3 |
using liquid | 3 |
large acute | 3 |
healthcare institutes | 3 |
may even | 3 |
emergency response | 3 |
extensive splashing | 3 |
designated covid | 3 |
bronchoalveolar lavage | 3 |
clinical infection | 3 |
adjusted incidence | 3 |
american society | 3 |
asymptomatic coronavirus | 3 |
multidrug resistant | 3 |
hand drying | 3 |
amongst healthcare | 3 |
epidemiological study | 3 |
gel electrophoresis | 3 |
time points | 3 |
vancomycin resistant | 3 |
improving hand | 3 |
ppe guidance | 3 |
respiratory complaints | 3 |
successfully captured | 3 |
provide training | 3 |
development summit | 3 |
wear ppe | 3 |
costs associated | 3 |
collection losses | 3 |
independently associated | 3 |
considerable proportion | 3 |
wide variety | 3 |
contracted covid | 3 |
several factors | 3 |
door opened | 3 |
iss sessions | 3 |
air temperature | 3 |
tile surfaces | 3 |
positive correlation | 3 |
golden syrian | 3 |
sought medical | 3 |
risk associated | 3 |
larger scale | 3 |
virus disease | 3 |
authors suggested | 3 |
gram negative | 3 |
catheter may | 3 |
taken within | 3 |
urinary tracts | 3 |
task force | 3 |
categorical variables | 3 |
evaluated sodium | 3 |
healthy population | 3 |
health effects | 3 |
blood components | 3 |
general principles | 3 |
asymptomatic infections | 3 |
eight patients | 3 |
recent studies | 3 |
indoor environment | 3 |
korean government | 3 |
implanted venous | 3 |
series analysis | 3 |
made aware | 3 |
air humidity | 3 |
prospective randomized | 3 |
travel history | 3 |
term urinary | 3 |
successfully used | 3 |
ultraviolet light | 3 |
disease risk | 3 |
long term | 3 |
immune response | 3 |
deep vein | 3 |
hand flora | 3 |
nurse supervisors | 3 |
increased infection | 3 |
residual proteinaceous | 3 |
mrsa rates | 3 |
national hospital | 3 |
femoral site | 3 |
outpatient settings | 3 |
results converted | 3 |
restrictive antibiotic | 3 |
reduce surgical | 3 |
infectious agent | 3 |
size distribution | 3 |
tipped urinary | 3 |
clinical outcome | 3 |
reported significantly | 3 |
tb patients | 3 |
terminal cleaning | 3 |
compliance among | 3 |
education interventions | 3 |
negative control | 3 |
hcws exposed | 3 |
scoping review | 3 |
ebola virus | 3 |
reduced mortality | 3 |
single interventions | 3 |
clinicopathological outcomes | 3 |
respirators contaminated | 3 |
nurses working | 3 |
health risk | 3 |
kaplan meier | 3 |
born babies | 3 |
including prion | 3 |
ppe kits | 3 |
serratia marcescens | 3 |
declining thereafter | 3 |
unit patients | 3 |
laboratory diagnostics | 3 |
one type | 3 |
vaporous hydrogen | 3 |
influenza viruses | 3 |
room disinfection | 3 |
minor flow | 3 |
regression analysis | 3 |
higher hh | 3 |
protective devices | 3 |
facilities available | 3 |
intravenous access | 3 |
catheter material | 3 |
including two | 3 |
least somewhat | 3 |
health problems | 3 |
centre study | 3 |
patient comfort | 3 |
patients whose | 3 |
successful capture | 3 |
still air | 3 |
nanoparticle emulsion | 3 |
filtration log | 3 |
general anaesthesia | 3 |
health administration | 3 |
studies included | 3 |
also suggested | 3 |
log viral | 3 |
infected healthcare | 3 |
clinical gloves | 3 |
coated latex | 3 |
madrid autonomous | 3 |
chosen sampler | 3 |
mrsa clinical | 3 |
wipes decrease | 3 |
remains unclear | 3 |
extensive barrier | 3 |
settling velocity | 3 |
saves time | 3 |
ultrasonic cleaning | 3 |
health nurse | 3 |
previous years | 3 |
mouth masks | 3 |
financial constraints | 3 |
catheter group | 3 |
prophylactic oseltamivir | 3 |
prevention among | 3 |
using two | 3 |
based bioaerosol | 3 |
design features | 3 |
particle loss | 3 |
residual chemicals | 3 |
commercial cleaning | 3 |
protection ffp | 3 |
safety outcomes | 3 |
quality assurance | 3 |
pyeongtaek st | 3 |
average age | 3 |
frequent disinfection | 3 |
hicpac reviewed | 3 |
remaining infectious | 3 |
univariate analysis | 3 |
respirator decontamination | 3 |
aeration cycle | 3 |
hajj pilgrimage | 3 |
subclavian veins | 3 |
nhs hospital | 3 |
silver sulfadiazene | 3 |
viral etiology | 3 |
epidemic generation | 3 |
infected workers | 3 |
disinfect surfaces | 3 |
airway management | 3 |
including patients | 3 |
early diagnosis | 3 |
cases presenting | 3 |
might also | 3 |
prion decontamination | 3 |
increasing number | 3 |
following multiple | 3 |
highly suspected | 3 |
meatal cleansing | 3 |
disease outbreak | 3 |
maternal antibodies | 3 |
elderly patients | 3 |
based study | 3 |
jet impactors | 3 |
unique response | 3 |
positive covid | 3 |
social marketing | 3 |
colonisation pressure | 3 |
particle content | 3 |
cov rtepcr | 3 |
highly prevalent | 3 |
collection chamber | 3 |
flow resistance | 3 |
virus infectivity | 3 |
sharps safety | 3 |
transmitted via | 3 |
acquiring covid | 3 |
reduce nosocomial | 3 |
hd treatment | 3 |
isolation conditions | 3 |
short peripheral | 3 |
important information | 3 |
hospital outbreaks | 3 |
protection level | 3 |
face shield | 3 |
preventing hcai | 3 |
medical advice | 3 |
disinfectant products | 3 |
cluster randomised | 3 |
also become | 3 |
absolute values | 3 |
patients received | 3 |
antiseptic agent | 3 |
skin cleansing | 3 |
provide employees | 3 |
decontamination protocol | 3 |
international concern | 3 |
patients infected | 3 |
technological advances | 3 |
data exist | 3 |
syndrome outbreak | 3 |
culturable airborne | 3 |
antimicrobial ointment | 3 |
many areas | 3 |
patient exposure | 3 |
medical patients | 3 |
labour costs | 3 |
kangaroo care | 3 |
clean care | 3 |
decontamination practices | 3 |
laminate bags | 3 |
patients compared | 3 |
south africa | 3 |
pediatric unit | 3 |
global spread | 3 |
technologically advanced | 3 |
advanced units | 3 |
staff groups | 3 |
effective measures | 3 |
unnecessary use | 3 |
single hospital | 3 |
decreasing catheter | 3 |
silver oxide | 3 |
mask materials | 3 |
viable pathogens | 3 |
studies also | 3 |
reduction factors | 3 |
ffp respirator | 3 |
poor settings | 3 |
complications associated | 3 |
average incidence | 3 |
virus particles | 3 |
susceptible site | 3 |
four ffr | 3 |
intervention studies | 3 |
years admitted | 3 |
evaluated interventions | 3 |
family clusters | 3 |
used routinely | 3 |
onward transmission | 3 |
statistical significance | 3 |
patient cases | 3 |
healthcareassociated infections | 3 |
remain viable | 3 |
study shows | 3 |
aerodynamic analysis | 3 |
particulate filtration | 3 |
care patients | 3 |
skin care | 3 |
indoor environments | 3 |
high viral | 3 |
lumen cvcs | 3 |
ffr model | 3 |
higher flow | 3 |
research question | 3 |
whole masks | 3 |
interior environments | 3 |
low pathogenicity | 3 |
improve compliance | 3 |
sterilisation centre | 3 |
volatile organic | 3 |
decontaminate hands | 3 |
one controlled | 3 |
microbial volatile | 3 |
faecal samples | 3 |
alcoholic chg | 3 |
term use | 3 |
tertiary referral | 3 |
public hospital | 3 |
mild respiratory | 3 |
curves using | 3 |
nursing personnel | 3 |
using silver | 3 |
evidence based | 3 |
protecting health | 3 |
studies showed | 3 |
bacteria isolated | 3 |
new safety | 3 |
patients reported | 3 |
caseecontrol study | 3 |
ward closure | 3 |
initial filter | 3 |
will reduce | 3 |
hospital reported | 3 |
sampling bias | 3 |
low birth | 3 |
tropical africa | 3 |
commercially available | 3 |
first stage | 3 |
rna positivity | 3 |
decontaminated following | 3 |
whenever possible | 3 |
many nosocomial | 3 |
hygiene audit | 3 |
warm air | 3 |
infection risks | 3 |
candida albicans | 3 |
little change | 3 |
control samples | 3 |
patient room | 3 |
pathogens without | 3 |
standards institution | 3 |
step handwashing | 3 |
mean difference | 3 |
virus dna | 3 |
taste testing | 3 |
combined throat | 3 |
particle inertia | 3 |
microbiological features | 3 |
airborne bacterial | 3 |
ultrasonic activated | 3 |
main mode | 3 |
peroxide gas | 3 |
effective preventive | 3 |
health services | 3 |
origin influenza | 3 |
surgical incisions | 3 |
nrl gloves | 3 |
narrative reviews | 3 |
chemical methods | 3 |
work regulations | 3 |
paper towels | 3 |
prevention precautions | 3 |
cycles using | 3 |
cardiovascular disease | 3 |
cfu ml | 3 |
evidence related | 3 |
emergency medical | 3 |
current covid | 3 |
nosocomial influenza | 3 |
coated central | 3 |
mm kcl | 3 |
surgical inpatients | 3 |
sampling probe | 3 |
intravenous administration | 3 |
health board | 3 |
secondary spread | 3 |
upper gastrointestinal | 3 |
deposition build | 3 |
rna negative | 3 |
prevent infection | 3 |
infections including | 3 |
ciprofloxacin resistant | 3 |
aid clinical | 3 |
via droplets | 3 |
least three | 3 |
contamination likelihoods | 3 |
significant impact | 3 |
positive cultures | 3 |
current situation | 3 |
samples collected | 3 |
higher viral | 3 |
clean hands | 3 |
twice daily | 3 |
paediatric setting | 3 |
empirical treatment | 3 |
catheter infection | 3 |
outbreak management | 3 |
control methods | 3 |
based exposure | 3 |
review protocol | 3 |
transmission accounted | 3 |
vivo infection | 3 |
existing evidence | 3 |
pregnant women | 3 |
door handles | 3 |
potential health | 3 |
moderate success | 3 |
pcr positive | 3 |
minimizing risk | 3 |
ivad healthcare | 3 |
financial support | 3 |
invasive medical | 3 |
data suggest | 3 |
national university | 3 |
korean hospitals | 3 |
inconveniently located | 3 |
airborne adenovirus | 3 |
malaysian maternity | 3 |
positive control | 3 |
many non | 3 |
text screening | 3 |
reduced bloodstream | 3 |
global patient | 3 |
bacillus cereus | 3 |
predominantly transmitted | 3 |
additional supplies | 3 |
korean mers | 3 |
high concentrations | 3 |
two hundred | 3 |
provide safe | 3 |
washing rates | 3 |
resistant strains | 3 |
increased medical | 3 |
google scholar | 3 |
quality assessment | 3 |
hepa air | 3 |
human rotavirus | 3 |
test methods | 3 |
health risks | 3 |
large hospitals | 3 |
oral transmission | 3 |
also recommend | 3 |
microwave irradiation | 3 |
standard precautions | 3 |
patient facing | 3 |
database search | 3 |
including mrsa | 3 |
associated diarrhoea | 3 |
moderate symptoms | 3 |
north west | 3 |
administration set | 3 |
associated bronchiolitis | 3 |
sterile service | 3 |
particles larger | 3 |
may give | 3 |
subclavian catheters | 3 |
patients attendants | 3 |
carbon dioxide | 3 |
community incidence | 3 |
needle safety | 3 |
endotracheal tubes | 3 |
tract pathogens | 3 |
hd units | 3 |
steam sterilisation | 3 |
limited evidence | 3 |
year study | 3 |
cile spores | 3 |
infection compared | 3 |
two particles | 3 |
reduce sickness | 3 |
real world | 3 |
sites may | 3 |
detailed history | 3 |
representative sample | 3 |
safe disposal | 3 |
guidelines apply | 3 |
case data | 3 |
may require | 3 |
electret masks | 3 |
uenza virus | 3 |
using matlab | 3 |
evaluated using | 3 |
suspected patients | 3 |
respirator material | 3 |
care setting | 3 |
rub formulations | 3 |
medical ward | 3 |
gradual geographic | 3 |
environmental factors | 3 |
previously published | 3 |
hcp working | 3 |
also contribute | 3 |
per hospital | 3 |
diagnosis may | 3 |
four stakeholders | 3 |
large numbers | 3 |
absolute fe | 3 |
catheter removal | 3 |
temporary catheters | 3 |
pathogens using | 3 |
high temperature | 3 |
decontaminate rooms | 3 |
every days | 3 |
opening motion | 3 |
seal competency | 3 |
control teams | 3 |
spunlace mask | 3 |
may cause | 3 |
safety device | 3 |
early mitigation | 3 |
technical assistance | 3 |
particle bounce | 3 |
management issue | 3 |
daily cleaning | 3 |
studies met | 3 |
permeable polyurethane | 3 |
viral infection | 3 |
study leads | 3 |
ebola outbreak | 3 |
piece respirator | 3 |
hands using | 3 |
guidelines indicate | 3 |
coronavirus pneumonia | 3 |
npa testing | 3 |
vena cava | 3 |
specific grant | 3 |
arabian peninsula | 3 |
caused long | 3 |
sikh dentists | 3 |
rapid method | 3 |
allowed us | 3 |
nov ggi | 3 |
guidance covid | 3 |
phylogenetic analysis | 3 |
underlying condition | 3 |
infectious titer | 3 |
mm trisehcl | 3 |
strong germicidal | 3 |
ciency virus | 3 |
susceptibility pattern | 3 |
remaining two | 3 |
staff might | 3 |
laboratory staff | 3 |
case reports | 3 |
water tank | 3 |
important lessons | 3 |
ventilation rates | 3 |
medical education | 3 |
cleaning efficacy | 3 |
immediately following | 3 |
bacterial indicators | 3 |
described earlier | 3 |
maintained following | 3 |
patient outcomes | 3 |
sought information | 3 |
uk hospitals | 3 |
modal interventions | 3 |
models tested | 3 |
human resources | 3 |
randomized study | 3 |
also concern | 3 |
individual hcw | 3 |
relative survival | 3 |
environmental samples | 3 |
surgical gown | 3 |
adequate fit | 3 |
reminder systems | 3 |
top priority | 3 |
wearing surgical | 3 |
prevent nosocomial | 3 |
infections due | 3 |
confined spaces | 3 |
neutropenic patients | 3 |
mask layers | 3 |
ffrs following | 3 |
care must | 3 |
authors declare | 3 |
needleless connectors | 3 |
hygiene programme | 3 |
mental health | 3 |
general recommendations | 3 |
nine studies | 3 |
larger static | 3 |
ceramic tiles | 3 |
cohort wards | 3 |
patient populations | 3 |
intravascular device | 3 |
another patient | 3 |
study heterogeneity | 3 |
like bacteria | 3 |
hiv aids | 3 |
lysis buffer | 3 |